Abstract:Objective To study the anti-HBV activity and toxicity of a novel MCC-478 devivative 030705 with specific structure in vitro.Methods Anti-HBV activities in HepG2.2.15 cells were analyzed by Southern blotting in experimental groups with different doses of 030705(0.01,0.03,0.10,0.30 and 1.0 μmol·L-1)and Adefovir Dipioxil positive control groups(0.10,0.30,1.0,3.0 and 10.0 μmol·L1).Concentration of 50% inhibitation(IC50)and concentration of 90% inhibitation(IC90) were obtained.The inhibitory effect of HBeAg was analyzed in HepG2.2.15 cells by ELISA method.The cytotoxicities were tested by MTT method in the experimental groups(10,30,100,300 and 1 000 μmol·L-1) in HepG2 cells.Concentration of 50% extinction(CC50) was obtained.The inhibitory effects of mitochondrial DNA contents in experimental groups(0.10,1.0 and 10 μmol·L-1)were tested by Dot blotting in HepG2 cells.While didenoxycytidine(ddC) groups were as positive control groups and untreated groups were as negative groups.Results Compared with Adefovir Dipioxil positive control groups,the inhibitory effects of the test compound 030705 on HBV DNA had no obvious difference(P0.05).Anti-HBV activity of the test compound 030705 was similar to that of Adefovir Dipioxil in HepG2.2.15 cells.The inhibitory rates of HBeAg in experimental groups(0.01,0.03,0.10,0.30 and 1.0 μmol·L-1 030705)were 5.94%,6.08%,6.32%,10.31% and 12.49%,respectively in HepG2.2.15 cells;compared with negative control group,there was no obvious difference(P0.05).CC50 value of the test compound was 2 014 μmol·L-1(1 000 μmol·L-1) in HepG2 cells.The inhibitory rates of mitochondrial DNA content from positive drug ddC(0.10,1.0 and 10 μmol·L-1)were 38.43%,46.51%,56.51%,respectively in HepG2 cells;compared with negative control group,there was obvious difference(P0.05).The inhibitory rates of mitochondrial DNA content from the test compound 030705 with the same concentrations were 7.00%,5.81%,5.78%, respectively in HepG2 cells;compared with negative control group,there was no obvious difference(P0.05).Conclusion Anti-HBV activity of the test compound 030705 was similar to that of Adefovir Dipioxil in HepG2.2.15 cells.CC50 value of the test compound is 2014 μmol·L-1(1 000 μmol·L-1) in HepG2 cells.No apparent reductions of mitochondrial DNA content are observed in HepG2 cells.The test compound 030705 with specific structure may be a new promising anti-HBV agent.

5-Iodo-2-arylalkylthio-6-aryl pyrimidin-4(3H)-ones as non-nucleoside anti-HBV agents

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication.

2-Arylthio-5-iodo Pyrimidine Derivatives As Non-Nucleoside HBV Polymerase Inhibitors

Synthesis and Anti-HBV Activity of Novel Dihydropyrimidine Analogs

Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors

Synthesis and Antiviral Activity of New Acrylamide Derivatives Containing 1,2,3-Thiadiazole As Inhibitors of Hepatitis B Virus Replication

Synthesis And Biological Evaluation Of Novel 5-Alkyl-2-Arylthio-6-((3,4-Dihydroquinolin-1(2h)-Yl)Methyl)Pyrimidin-4(3 H)-Ones As Potent Non-Nucleoside Hiv-1 Reverse Transcriptase Inhibitors

Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.

Synthesis and Biological Evaluation of Novel 2-Arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3h)-ones As Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.

Antiviral Effects of Three Novel Derivatives of Adefovir on the Replication of Hepatitis B Virus

Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.

Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives

Optimization and Synthesis of Pyridazinone Derivatives As Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation

Synthesis and Anti-HIV-1 Activity Evaluation of 5-Alkyl-2-alkylthio-6-(arylcarbonyl or Α-Cyanoarylmethyl)-3,4-dihydropyrimidin-4(3h)-ones As Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Synthesis and Anti-HBV Activity of Novel 3′-N-phenylsulfonyl Docetaxel Analogs

A Novel Pyridazinone Derivative Inhibits Hepatitis B Virus Replication by Inducing Genome-Free Capsid Formation

Anti-hepatitis B Virus Activity and Toxicity of a Novel Nucleoside Analogues in Vitro

Non‐nucleoside HIV Reverse Transcriptase Inhibitors, Part 6[1]: Synthesis and Anti‐HIV Activity of Novel 2‐[(arylcarbonylmethyl)thio]‐6‐arylthio DABO Analogues

Panaxadiol and panaxatriol derivatives as anti-hepatitis B virus inhibitors